Anthony C Vernon1, William R Crum2, Jason P Lerch3, Winfred Chege1, Sridhar Natesan1, Michel Modo4, Jonathan D Cooper4, Steven C R Williams2, Shitij Kapur5. 1. Department of Psychosis Studies. 2. Department of Neuroimaging, Centre for Neuroimaging Sciences. 3. Mouse Imaging Centre, The Hospital for Sick Children and Department of Medical Biophysics, University of Toronto, Toronto, Canada. 4. Department of Neuroscience, Centre for the Cellular Basis of Behaviour, The James Black Centre, King's College London, Institute of Psychiatry. 5. Department of Psychosis Studies. Electronic address: shitij.kapur@kcl.ac.uk.
Abstract
BACKGROUND: Increasing evidence suggests that antipsychotic drugs (APD) might affect brain structure directly, particularly the cerebral cortex. However, the precise anatomical loci of these effects and their underlying cellular basis remain unclear. METHODS: With ex vivo magnetic resonance imaging in rats treated chronically with APDs, we used automated analysis techniques to map the regions that show maximal impact of chronic (8 weeks) treatment with either haloperidol or olanzapine on the rat cortex. Guided by these imaging findings, we undertook a focused postmortem investigation with stereology. RESULTS: We identified decreases in the volume and thickness of the anterior cingulate cortex (ACC) after chronic APD treatment, regardless of the APD administered. Postmortem analysis confirmed these volumetric findings and demonstrated that chronic APD treatment had no effect on the total number of neurons or S100β+ astrocytes in the ACC. In contrast, an increase in the density of these cells was observed. CONCLUSIONS: This study demonstrates region-specific structural effects of chronic APD treatment on the rat cortex, primarily but not exclusively localized to the ACC. At least in the rat, these changes are not due to a loss of either neurons or astrocytes and are likely to reflect a loss of neuropil. Although caution needs to be exerted when extrapolating results from animals to patients, this study highlights the power of this approach to link magnetic resonance imaging findings to their histopathological origins.
BACKGROUND: Increasing evidence suggests that antipsychotic drugs (APD) might affect brain structure directly, particularly the cerebral cortex. However, the precise anatomical loci of these effects and their underlying cellular basis remain unclear. METHODS: With ex vivo magnetic resonance imaging in rats treated chronically with APDs, we used automated analysis techniques to map the regions that show maximal impact of chronic (8 weeks) treatment with either haloperidol or olanzapine on the rat cortex. Guided by these imaging findings, we undertook a focused postmortem investigation with stereology. RESULTS: We identified decreases in the volume and thickness of the anterior cingulate cortex (ACC) after chronic APD treatment, regardless of the APD administered. Postmortem analysis confirmed these volumetric findings and demonstrated that chronic APD treatment had no effect on the total number of neurons or S100β+ astrocytes in the ACC. In contrast, an increase in the density of these cells was observed. CONCLUSIONS: This study demonstrates region-specific structural effects of chronic APD treatment on the rat cortex, primarily but not exclusively localized to the ACC. At least in the rat, these changes are not due to a loss of either neurons or astrocytes and are likely to reflect a loss of neuropil. Although caution needs to be exerted when extrapolating results from animals to patients, this study highlights the power of this approach to link magnetic resonance imaging findings to their histopathological origins.
Authors: S E Holmes; R Hinz; R J Drake; C J Gregory; S Conen; J C Matthews; J M Anton-Rodriguez; A Gerhard; P S Talbot Journal: Mol Psychiatry Date: 2016-10-04 Impact factor: 15.992
Authors: Ariel G Gildengers; Meryl A Butters; Howard J Aizenstein; Megan M Marron; James Emanuel; Stewart J Anderson; Lisa A Weissfeld; James T Becker; Oscar L Lopez; Benoit H Mulsant; Charles F Reynolds Journal: Bipolar Disord Date: 2014-09-25 Impact factor: 6.744
Authors: Eric A Nelson; Nina V Kraguljac; David M White; Ripu D Jindal; Ah L Shin; Adrienne C Lahti Journal: Can J Psychiatry Date: 2020-02-05 Impact factor: 4.356
Authors: Aristotle N Voineskos; Benoit H Mulsant; Erin W Dickie; Nicholas H Neufeld; Anthony J Rothschild; Ellen M Whyte; Barnett S Meyers; George S Alexopoulos; Matthew J Hoptman; Jason P Lerch; Alastair J Flint Journal: JAMA Psychiatry Date: 2020-07-01 Impact factor: 21.596
Authors: Christoph Anacker; Jan Scholz; Kieran J O'Donnell; Rylan Allemang-Grand; Josie Diorio; Rosemary C Bagot; Eric J Nestler; René Hen; Jason P Lerch; Michael J Meaney Journal: Biol Psychiatry Date: 2015-08-18 Impact factor: 13.382
Authors: Tobias B Halene; Alexey Kozlenkov; Yan Jiang; Amanda C Mitchell; Behnam Javidfar; Aslihan Dincer; Royce Park; Jennifer Wiseman; Paula L Croxson; Eustathia Lela Giannaris; Patrick R Hof; Panos Roussos; Stella Dracheva; Scott E Hemby; Schahram Akbarian Journal: Schizophr Res Date: 2016-01-06 Impact factor: 4.939